Research Article
Beneficial Effects of Ursodeoxycholic Acid on Metabolic Parameters and Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind, Placebo-Controlled Clinical Study
Table 2
Glucoregulation and lipid status at baseline and after eight weeks of UDCA or placebo treatment.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
All values are expressed as or median (IQR). F0: beginning of study; F1: end of study; HbA1c: glycosylated hemoglobin A1c; HOMA IR: Homeostatic Model Assessment index; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol. |